Tingling Hands and Feet But Not Diabetic? 12 Surprising Causes of Peripheral Neuropathy

That Pins-and-Needles Feeling That Won't Go Away

Your doctor ruled out diabetes. Blood sugar? Normal. A1C? Perfect. So why do your feet feel like they're wrapped in static electricity every night?

You're not imagining it. And you're definitely not alone. About 30% of peripheral neuropathy cases have nothing to do with diabetes, according to a 2024 analysis in Lancet Neurology. That's roughly 6 million Americans walking around with nerve damage from causes that often fly under the radar during routine checkups.

I spent three years with tingling toes before anyone thought to check my B12 levels. Spoiler: they were in the basement. The frustrating part? A simple blood test could have caught it years earlier.

Your Nerves Are Talking—Here's What They Might Be Saying

Peripheral neuropathy is essentially your nervous system sending garbled messages. The peripheral nerves—the ones outside your brain and spinal cord—get damaged, and suddenly your body's communication network goes haywire.

The symptoms show up in predictable patterns. Tingling usually starts in the toes or fingertips. It creeps upward over months or years, like water slowly filling a glove or sock. Some people describe burning. Others feel nothing at all, which sounds like a relief until you realize you can't tell when you've stepped on something sharp.

Small fiber neuropathy, which primarily affects pain and temperature sensation, now accounts for nearly half of all "idiopathic" neuropathy cases that get properly worked up. A 2025 review in Neurology found that 47% of patients initially labeled with "unknown cause" neuropathy actually had identifiable small fiber damage when tested with skin punch biopsy.

The B12 Connection: More Common Than You'd Think

Vitamin B12 deficiency causes neuropathy in about 15-20% of non-diabetic cases. The tricky part? Your B12 levels can look "normal" on standard tests while your nerves are already suffering.

Here's why. The conventional cutoff for B12 deficiency sits around 200 pg/mL. But neurological symptoms can start appearing at levels below 400. A 63-year-old vegetarian might have a B12 of 280—technically "fine"—while her myelin sheaths are slowly deteriorating.

Certain groups face higher risk. Vegans and vegetarians, obviously, since B12 comes primarily from animal products. But also anyone over 50 (stomach acid production drops, reducing B12 absorption), people taking metformin or proton pump inhibitors long-term, and those with celiac disease or Crohn's.

The good news: caught early, B12 neuropathy often reverses completely with supplementation. Caught late, the damage becomes permanent.

Autoimmune Disorders: When Your Body Attacks Its Own Wiring

Your immune system is supposed to protect you. Sometimes it gets confused and starts attacking your peripheral nerves instead.

Guillain-Barré syndrome gets the headlines because it's dramatic—rapid onset paralysis, often following an infection. But chronic inflammatory demyelinating polyneuropathy (CIDP) is actually more common, affecting about 5 per 100,000 people. It develops slowly, over months, and often gets misattributed to "aging" or "stress."

Sjögren's syndrome, best known for causing dry eyes and mouth, triggers small fiber neuropathy in roughly 20% of patients. Many of them experience the nerve symptoms before the classic dryness appears. Lupus, rheumatoid arthritis, and vasculitis can all damage peripheral nerves through inflammation or reduced blood flow.

The autoimmune workup typically includes ANA, anti-SSA/SSB antibodies, and sometimes a lip biopsy for Sjögren's. These aren't part of routine bloodwork, which explains why autoimmune neuropathy often takes 3-5 years to get properly identified.

Toxic Neuropathy: The Chemicals in Your Medicine Cabinet (and Garage)

Chemotherapy-induced peripheral neuropathy affects 30-40% of cancer patients, depending on the drug regimen. Taxanes, platinum compounds, and vinca alkaloids are the worst offenders. For some patients, the neuropathy persists years after treatment ends.

But you don't need chemo to develop toxic neuropathy. Alcohol is the second most common cause of peripheral neuropathy in developed countries, right behind diabetes. Heavy drinking—defined as more than 3-4 drinks daily over years—directly damages nerve fibers while also depleting B vitamins.

Other culprits hiding in plain sight: certain antibiotics (metronidazole, fluoroquinolones), the heart medication amiodarone, and some HIV medications. Industrial solvents, lead, and arsenic exposure can trigger neuropathy too, though these cases are rarer.

One patient I know developed severe neuropathy from taking high-dose vitamin B6 supplements—over 200mg daily for months. B6 toxicity is real, and it causes the exact symptoms people are trying to prevent.

Inherited Neuropathies: The Genetic Wild Card

Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy, affecting about 1 in 2,500 people. It typically shows up in adolescence or early adulthood with high arches, hammer toes, and progressive weakness in the lower legs.

But here's what catches people off guard: some genetic neuropathies don't manifest until middle age. Hereditary transthyretin amyloidosis (hATTR) often presents in the 50s or 60s with tingling feet and autonomic symptoms like constipation or dizziness. Until recently, it was considered untreatable. New gene-silencing therapies have changed that equation entirely.

Family history matters, but absence of family history doesn't rule out genetic causes. De novo mutations happen. Mild cases in previous generations might have gone unnoticed or been attributed to other conditions.

The Thyroid-Nerve Connection

Hypothyroidism causes peripheral neuropathy in about 40% of untreated cases. The mechanism involves both direct nerve damage and fluid retention that compresses nerves—carpal tunnel syndrome is especially common.

What's less appreciated: even "subclinical" hypothyroidism (TSH slightly elevated, T4 normal) can contribute to neuropathy symptoms. A 2024 study found that treating subclinical hypothyroidism improved neuropathy scores in 60% of patients over 6 months.

Hyperthyroidism causes neuropathy too, though less frequently. The relationship works both ways—some autoimmune thyroid conditions and autoimmune neuropathies share underlying mechanisms.

Kidney Disease: The Silent Nerve Killer

Uremic neuropathy affects 60-90% of patients with end-stage kidney disease. But nerve damage can begin much earlier, when kidney function drops below 30% of normal. The exact mechanism isn't fully understood—probably a combination of toxin accumulation and metabolic disturbances.

Many people don't know their kidney function is declining until it's significantly impaired. A basic metabolic panel includes creatinine, but the estimated GFR (glomerular filtration rate) tells the fuller story. Anyone with unexplained neuropathy should have their kidney function thoroughly evaluated.

Infections That Target Nerves

Shingles (herpes zoster) can cause postherpetic neuralgia—persistent nerve pain that lasts months or years after the rash heals. About 10-18% of shingles patients develop this complication, with risk increasing sharply after age 60.

Lyme disease causes neuropathy in its later stages, sometimes appearing months after the initial tick bite. HIV can cause neuropathy both directly (the virus damages nerves) and indirectly (through medications or immune dysfunction). Hepatitis C is associated with neuropathy through cryoglobulinemia, an abnormal protein response.

Leprosy remains the most common infectious cause of neuropathy worldwide, though it's rare in developed countries. The point is that infection should be on the differential, especially if neuropathy develops after travel or illness.

Getting the Right Workup: What to Ask For

A thorough neuropathy evaluation goes beyond basic blood tests. The Lancet Neurology 2024 guidelines recommend a tiered approach.

First tier (everyone with unexplained neuropathy): fasting glucose, HbA1c, complete metabolic panel, TSH, B12, folate, complete blood count, and serum protein electrophoresis. This catches the most common causes.

Second tier (if first tier is negative): methylmalonic acid (more sensitive for B12 deficiency), ANA, ESR, hepatitis panel, HIV test, and Lyme antibodies in endemic areas.

Third tier (specialized testing): nerve conduction studies and electromyography (EMG) to characterize the neuropathy pattern, skin punch biopsy for small fiber neuropathy, lumbar puncture if inflammatory causes are suspected, and genetic testing if hereditary neuropathy is possible.

The 2025 Neurology review emphasizes that skin biopsy has become essential for diagnosing small fiber neuropathy—nerve conduction studies miss it entirely because they only assess large fibers.

Treatment Depends on Finding the Cause

Here's the critical point: treating neuropathy symptoms without addressing the underlying cause is like mopping the floor while the faucet's still running.

B12 deficiency? Supplementation can halt progression and often reverse symptoms if caught within 6-12 months of onset. Autoimmune neuropathy? Immunotherapy (IVIG, steroids, plasma exchange) can be remarkably effective. Toxic neuropathy? Remove the toxin and wait—nerves regenerate slowly, about 1mm per day, but they do regenerate.

For symptom management, options include gabapentin, pregabalin, duloxetine, and topical lidocaine. These don't fix the underlying problem but can make life more bearable while the nerves heal—or if the damage is irreversible.

Physical therapy helps maintain strength and balance. Occupational therapy can teach compensatory strategies for fine motor tasks. Some patients benefit from transcutaneous electrical nerve stimulation (TENS) or acupuncture, though evidence quality varies.

When to Push for More Answers

If your symptoms are progressing—spreading higher, getting worse, affecting function—don't accept "idiopathic" as a final answer. Push for the second and third tier workup. Ask for a neurology referral if you haven't seen a specialist.

Red flags that warrant urgent evaluation: rapid onset (days to weeks), significant weakness, difficulty breathing or swallowing, or autonomic symptoms like fainting, severe constipation, or urinary retention. These could indicate Guillain-Barré syndrome or other conditions requiring immediate treatment.

The average time from symptom onset to neuropathy identification is 4.2 years, according to one patient registry study. That's 4.2 years of potential nerve damage that might have been prevented or reversed with earlier intervention.

Your tingling feet are telling you something. The question is whether anyone's listening carefully enough to figure out what.